{"version":1,"type":"story","url":"https://digestai.news/story/avenda-health-launches-surgery-mode-for-intraoperative-use-of-unfold-a","json":"https://digestai.news/story/avenda-health-launches-surgery-mode-for-intraoperative-use-of-unfold-a.json","markdown":"https://digestai.news/story/avenda-health-launches-surgery-mode-for-intraoperative-use-of-unfold-a.md","slug":"avenda-health-launches-surgery-mode-for-intraoperative-use-of-unfold-a","headline":"Avenda Health launches Surgery Mode for intraoperative use of Unfold AI","summary":"Avenda Health announced Surgery Mode, a suite of intraoperative features that extend its Unfold AI platform into the operating room. The multimodal AI system creates a 3D map of prostate cancer, allowing surgeons to view enlarged visualizations, align risk scores with the camera view, and review MRI slices during procedures. The company says the expansion supports both robotic and non‑robotic surgeries and adds workflow tools for case management.\n\nAvenda Health reports that Unfold AI predicts cancer spread with 92% accuracy, compared with 52% using MRI alone. Peer‑reviewed research cited by the firm indicates the system can cut positive surgical margins in half and increase sensitivity for tumor extent identification from 37% to 97%. The CEO, Shyam Natarajan, Ph.D., said the new mode gives physicians visual confidence to achieve optimal cancer control while preserving quality of life.","keyPoints":["Avenda Health introduced Surgery Mode, adding intraoperative 3D AI mapping to its Unfold AI platform.","Unfold AI predicts cancer spread with 92% accuracy versus 52% for MRI alone.","Research shows sensitivity for tumor extent identification rose from 37% to 97% using Unfold AI."],"whyItMatters":"Intraoperative AI mapping could halve positive surgical margins and improve nerve‑sparing decisions, potentially reducing prostate cancer recurrence and preserving quality of life.","category":{"slug":"agents","name":"Agents & Tools","url":"https://digestai.news/category/agents"},"entities":{"companies":["Avenda Health"],"models":["Unfold AI"],"people":["Shyam Natarajan"]},"firstPublishedAt":"2026-10-20T12:59:43Z","updatedAt":"2026-10-20T12:59:43Z","sourceCount":1,"hasPrimarySource":false,"sources":[{"outlet":"The Robot Report","title":"Avenda Health expands Unfold AI platform to support intraoperative prostate cancer care","url":"https://therobotreport.com/avenda-health-expands-unfold-ai-platform-support-intraoperative-prostate-cancer-care","publishedAt":"2026-10-20T12:59:43Z","type":"press","primary":false,"lead":true}],"sourceNotes":null,"discussions":[],"thread":null,"cite":{"text":"Digest AI, \"Avenda Health launches Surgery Mode for intraoperative use of Unfold AI\", 20 October 2026, https://digestai.news/story/avenda-health-launches-surgery-mode-for-intraoperative-use-of-unfold-a","publisher":"Digest AI","title":"Avenda Health launches Surgery Mode for intraoperative use of Unfold AI","datePublished":"2026-10-20T12:59:43Z","url":"https://digestai.news/story/avenda-health-launches-surgery-mode-for-intraoperative-use-of-unfold-a"},"generatedBy":"Written by Digest AI's editorial model from the linked sources; the sources are the record.","license":"Headlines, digests and key points are written by Digest AI and may be quoted with a link to the story page. Linked articles belong to their publishers. Terms: https://digestai.news/terms#reuse"}